These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4861976)

  • 1. [Stimulation of antidysentery immunity with acetoxan].
    Gorbunova ES
    Antibiotiki; 1966 Apr; 11(4):354-8. PubMed ID: 4861976
    [No Abstract]   [Full Text] [Related]  

  • 2. Antidysentery immunoprophylaxis in the light of current data about the pathogenicity of Shigella and the antidysentery immunity.
    Meitert T
    Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):195-230. PubMed ID: 6443688
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies of crossed immunity between different serotypes of dysentery bacilli and the keratoconjunctivitis-positive, lactoso-negative strain 47552 deprived of Shigella agglutinogen].
    Ciufeco C
    Arch Roum Pathol Exp Microbiol; 1969; 28(2):389-94. PubMed ID: 4925072
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on acquired systemic resistance in mice with oral immunization with Shigella sonnei.
    Kowalewska D; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1980; 28(2):345-55. PubMed ID: 7004395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trials of Shigella vaccines in Israel.
    Cohen D; Ashkenazi S; Green M; Gdalevich M; Yavzori M; Orr N; Robin G; Slepon R; Lerman Y; Block C; Ashkenazi I; Taylor D; Hale L; Sadoff J; Schneerson R; Robbins J; Wiener M; Shemer J
    Adv Exp Med Biol; 1996; 397():159-67. PubMed ID: 8718595
    [No Abstract]   [Full Text] [Related]  

  • 6. [Study on the effectiveness of a Sh. sonnei oral vaccine using the direct plaque technic].
    Thilo W; Seeger E; Schlosshardt J; Kriehn I; Poeplau A
    Z Gesamte Hyg; 1972 Oct; 18(10):756-8. PubMed ID: 4581673
    [No Abstract]   [Full Text] [Related]  

  • 7. Adoptive transfer of immunity to dysentery bacilli with immune T lymphocytes from mice orally immunized with Shigella sonnei bacilli.
    Kowalewska D; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1980; 28(4):593-601. PubMed ID: 7006564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of antibody screening in selection of subjects for field trials of Shigella vaccines.
    Cohen D; Green MS; Block C; Rouach T; Ofek I; Swartz T; Lowell G; Tramont E
    Ann Sclavo Collana Monogr; 1986; 3(1-2):151-4. PubMed ID: 3322338
    [No Abstract]   [Full Text] [Related]  

  • 9. [Oral immunization of mice with Shigella sonnei antigens].
    Thilo W; Weister A
    J Hyg Epidemiol Microbiol Immunol; 1970; 14(3):294-302. PubMed ID: 4921005
    [No Abstract]   [Full Text] [Related]  

  • 10. Immune processes in the course of infection with dysentery bacilli. III. Protective activity of spleen cells and serum from mice immunized with killed dysentery bacilli.
    Kowalewska D; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1977; 25(1):69-78. PubMed ID: 327970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune processes in the course of infection with dysentery bacilli. IV. Transfer of immunity by means of fractions isolated from sera of mice immunized with dysentery bacilli.
    Wieczorek Z; Kowalewska D
    Arch Immunol Ther Exp (Warsz); 1980; 28(2):357-65. PubMed ID: 7004396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunity in Sonnei-dysentery].
    Birkovskiĭ IuE; Bondarenko VI; Alekseenko VV
    Vrach Delo; 1973 Sep; 9():148-52. PubMed ID: 4588531
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children.
    Passwell JH; Ashkenazi S; Harlev E; Miron D; Ramon R; Farzam N; Lerner-Geva L; Levi Y; Chu C; Shiloach J; Robbins JB; Schneerson R;
    Pediatr Infect Dis J; 2003 Aug; 22(8):701-6. PubMed ID: 12913770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shigella Sonnei vaccine.
    Drugs R D; 1999 Sep; 2(3):222-3. PubMed ID: 10641235
    [No Abstract]   [Full Text] [Related]  

  • 15. Immune processes induced by dysentery bacilli in mice.
    Kowalewska D; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):595-601. PubMed ID: 373684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nonspecific nature of antibody formation suppression by virulent Shigella sonnei].
    Borisov VA; Frolov AF
    Mikrobiol Zh (1978); 1982; 44(1):71-6. PubMed ID: 7040918
    [No Abstract]   [Full Text] [Related]  

  • 17. Laboratory control of oral Shigella sonnei vaccine.
    Starke G; Thilo W
    Prog Immunobiol Stand; 1970; 4():363-7. PubMed ID: 4921390
    [No Abstract]   [Full Text] [Related]  

  • 18. [A study of the streptomycin-dependent mutants of shigella].
    Sergeev VV; Taratorina OM; Elkina SI
    Zh Mikrobiol Epidemiol Immunobiol; 1967 Sep; 44(9):28-32. PubMed ID: 4892079
    [No Abstract]   [Full Text] [Related]  

  • 19. [Quantitative determination of Shigella sonnei antigens in urine of patients and bacterial carriers].
    Godovannyĭ BA; Litinskiĭ IuI; Bodisko VP; Demchenko MP; Mil'man EM; Karimova DKh; Khazanova LB; Trubolysova MA; Dul'tseva LP
    Lab Delo; 1970; 6():360-3. PubMed ID: 4195715
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunity to keratoconjunctivitis shigellosa in rabbits after oral immunization with Shigella sonnei free endotoxin.
    Kowalewska D; Mulczyk M
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):99-102. PubMed ID: 4613143
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.